Skip to content

Application of afentanil in bronchoscopy in children

Application of afentanil in bronchoscopy in children

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066130
Enrollment
Unknown
Registered
2022-11-25
Start date
2022-11-28
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pneumonia

Interventions

Test group 1:Propofol 2mg/kg+Afentanil 10ug/kg
control group 1:Propofol 2mg/kg+fentanyl 2ug/kg
control group 2:Propofol 2mg/kg+Normal saline 0.1ml/kg

Sponsors

Shenzhen Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. Age 3-6, gender unlimited; 2. Electronic bronchoscopy should be performed periodically; 3.ASA grading ?-?.

Exclusion criteria

Exclusion criteria: 1. Genetic history of mental illness, chromosomal abnormalities (such as Down syndrome); 2. Children with abnormal function of heart, liver, brain, kidney and other organs; 3. Children with congenital laryngeal osteomalacia, tracheal stenosis, respiratory failure or severe bronchial asthma; 4. Percutaneous blood oxygen saturation (SpO2<90%) under indoor air; 5. Have endocrine system diseases, such as hypothyroidism, etc.; 6. Severely malnourished or weighing more than 30 percent of standard body weight; 7. Refuse to participate in the clinical study.

Design outcomes

Primary

MeasureTime frame
Frequency of coughing episodes during the examination;

Secondary

MeasureTime frame
recovery time;The number and type of adverse events;Surgeon satisfaction;

Countries

China

Contacts

Public ContactSheng Wang

Shenzhen Children's Hospital

shengwang_gz@163.com+86 135 6018 2353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026